Szilard Voros
 | This biography of a living person needs additional citations for verification. (May 2017) (Learn how and when to remove this template message) |
| Szilard Voros | |
|---|---|
 Szilardvoros.jpg | |
| Born | Budapest, Hungary |
| 🏫 Education | University of Alabama at Birmingham (Residency), University Medical School of Pécs (M.D.) |
| 💼 Occupation | Cardiologist, Scientist |
Szilard Voros is a Hungarian-born American cardiologist and research scientist. He studies cardiovascular imaging, biomarkers, lipoprotein metabolism and genomics. He is an Associate Professor of Medicine/Cardiology and Radiology, and Director of Advanced Cardiovascular MR and CT Research at the Department of Radiology and Cardiology at Stony Brook University Medical Center, State University of New York. He previously served as the Chief Scientific Officer, Chief of Cardiovascular Prevention, and Medical Director of Cardiac MR and CT at Piedmont Hospital in Atlanta, Georgia, and as a Clinical Associate Professor of Medicine at the Medical College of Georgia. He is a founding member and Fellow of the Society of Cardiovascular Computed Tomography (FSCCT), Fellow of the American College of Cardiology (FACC) and Fellow of the American Heart Association (FAHA).
Biography[edit]
In 1996, as a summa cum laude graduate of the University Medical School of Pécs in Hungary, Voros moved to the United States to pursue his Internship and Residency in Internal Medicine at the University of Alabama at Birmingham from 1997 to 2000. In 2000, he was invited to serve as Clinical Instructor in Medicine and Chief Medical Resident at the University of Alabama at Birmingham.[1]
Voros has published extensively in the field of advanced cardiovascular imaging. He regularly lectures at national and international meetings, including many prestigious conferences sponsored by the American College of Cardiology.[2] Working with CardioDx, Inc (Palo Alto, CA), he recently published a paper in the Annals of Internal Medicine describing the first genomic blood-based diagnostic test for the detection of significant blockages in the heart.[3] Voros is independently funded to do important clinical research on advanced cardiovascular imaging, atherosclerosis and lipoprotein abnormalities. Voros and his team recently completed the ATLANTA I and ATLANTA II studies, which focused on assessing the morphology and other characteristics of blockages in the heart using heart catheterization, cardiac CT, intravascular ultrasound, and near infrared spectroscopy.
In 2010, Voros and his team published an article on their advanced method of coronary artery calcium quantification, the lesion-specific calcium score. This method has been shown, through research, to be superior to the Agatston score.
References[edit]
- ↑ "Interview with Szilard Voros, MD - Angioplasty.Org". Ptca.org. Retrieved 2011-08-08.
- ↑ "Szilard Voros". Wn.com. Retrieved 2011-08-08.
- ↑ Donna K. Arnett. "Multicenter Validation of the Diagnostic Accuracy of a Blood-Based Gene Expression Test for Assessing Obstructive Coronary Artery Disease in Nondiabetic Patients". Annals.org. Retrieved 2011-08-08.
This article "Szilard Voros" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Szilard Voros. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
